Company: INSP
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001140361-25-009249
Chunk: 36

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 36
---
 and the SEC. In addition, the Audit Committee received and reviewed the written disclosures and the letters from the Company’s independent registered public accounting firm required by applicable requirements of the PCAOB regarding such independent registered public accounting firm’s communications with the Audit Committee concerning independence, and discussed with the Company’s independent registered public accounting firm their independence from the Company. Based upon the review and discussions described in the preceding paragraph, the Audit Committee recommended to the Board that the Company’s audited consolidated financial statements be included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC. Submitted by the Audit Committee of the Company’s Board of Directors: Shawn T McCormick (Chair) Georgia Garinois-Melenikiotou Dana G. Mead, Jr.

| Inspire Medical Systems, Inc. |     | 31 |     | 2025 Proxy Statement |

TABLE OF CONTENTS

Executive Officers The table below identifies and sets forth certain biographical and other information regarding our executive officers as of March 18, 2025. There are no family relationships among any of our executive officers or directors.

| Executive Officer    |     | Age |     | Position                                                               |     |     In Current 
 Position Since |
| Timothy P. Herbert   |     |  62 |     | Chief Executive Officer, President, and Chair                          |     |           2007 |
| Richard J. Buchholz  |     |  57 |     | Chief Financial Officer                                                |     |           2014 |
| Randall A. Ban       |     |  60 |     | Executive Vice President, Patient Access and Therapy Development       |     |           2025 |
| Jason P. Kelly       |     |  45 |     | Chief Manufacturing and Quality Officer                                |     |           2025 |
| Melissa J. Mann      |     |  49 |     | Chief People Officer                                                   |     |           2024 |
| Bryan K. Phillips    |     |  53 |     | SVP, General Counsel, Chief Compliance Officer and Corporate Secretary |     |           2021 |
| John C. Rondoni      |     |  45 |     | Chief Technology Officer                                               |     |           2022 |
| Carlton W. Weatherby |     |  40 |     | Chief Strategy and Growth Officer                                      |     |           2024 |

See page 8of this Proxy Statement for Timothy P. Herbert’s biography